Company / Financials
OCULAR THERAPEUTIX, INC Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$52.0M
FY2025 · -18.5% YoY
Net Income
-$265.9M
FY2025 · -37.4% YoY
Profit Margin
-511.9%
FY2025 · net income / revenue
ROE
-40.6%
FY2025 · return on equity
Total Assets
$808.1M
FY2025
Total Debt
-
FY2025
Equity
$654.3M
FY2025
ROA
-32.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$52.0M-18.5% YoYNet Income HistoryProfit after all expenses and taxes-$265.9M-37.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$6.6M+16.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$270.0M-57.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$64.4M+6.1% YoYR&D Expense HistoryResearch and development spending$197.1M+54.4% YoYInterest Expense HistoryCost of borrowing and debt obligations$887.0K0.0% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$1.01-9.8% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$1.02-5.2% YoY